(Q36586992)

15 August 2017

1 reference

title

Amiodarone: a multifaceted antiarrhythmic drug (English)

1 reference

15 August 2017

1 reference

Bramah N Singh

1

1 reference

15 August 2017

publication date

1 September 2006

1 reference

Current cardiology reports

15 August 2017

published in

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

349-355

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-006-0074-2

15 August 2017

exact match

0 references

cites work

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

1 reference

https://api.crossref.org/works/10.1007%2FS11886-006-0074-2

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-006-0074-2

Low-dose amiodarone for atrial fibrillation: time for a prospective study?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-006-0074-2

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-006-0074-2

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-006-0074-2

Evidence-based analysis of amiodarone efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-006-0074-2

Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-006-0074-2

Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-006-0074-2

Amiodarone and Homogeneity of Ventricular Repolarization and Refractoriness

21 January 2018

1 reference

12 December 2020

Rise and Fall of Guided Antiarrhythmic Therapy for Ventricular Tachycardia and Fibrillation

1 reference

12 December 2020

Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs

1 reference

12 December 2020

Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators

1 reference

12 December 2020

Amiodarone versus sotalol for atrial fibrillation

1 reference

12 December 2020

Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent

1 reference

12 December 2020

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

1 reference

12 December 2020

Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions

1 reference

12 December 2020

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

12 December 2020

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

1 reference

12 December 2020

Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent.

1 reference

12 December 2020

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

12 December 2020

Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart

1 reference

12 December 2020

Pharmacology of amiodarone, and anti-anginal drug with a new biological profile

1 reference

12 December 2020

New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.

1 reference

12 December 2020

Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation

1 reference

12 December 2020

Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone

1 reference

12 December 2020

Overview of trends in the control of cardiac arrhythmia: past and future

1 reference

12 December 2020

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

1 reference

12 December 2020

Approaches to Controlling Cardiac Arrhythmias: Focus on Amiodarone, the Last 15 Years. Proceedings of a symposium. Dallas, Texas, USA. November 7, 1998

1 reference

12 December 2020

Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy

1 reference

12 December 2020

Atrial Fibrillation: Epidemiologic Considerations and Rationale for Conversion and Maintenance of Sinus Rhythm

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators

1 reference

12 December 2020

Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation

1 reference

12 December 2020

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

12 December 2020

Atrial fibrillation following investigation of rhythm management: AFFIRM trial outcomes. What might be their implications for arrhythmia control?

1 reference

12 December 2020

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

12 December 2020

Effect of carvedilol on survival in severe chronic heart failure

1 reference

12 December 2020

The coming of age of the class III antiarrhythmic principle: retrospective and future trends

1 reference

12 December 2020

Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications

1 reference

12 December 2020

Pursuit of sinus rhythm in patients with atrial fibrillation: is the effort worth it?

1 reference

12 December 2020

The burden of atrial fibrillation: should we abandon antiarrhythmic drug therapy?

1 reference

12 December 2020

10.1007/S11886-006-0074-2

Identifiers

DOI

1 reference

15 August 2017

1 reference